Small concentrations of albumin detected in the urine predict renal dy
sfunction and reflect vascular abnormalities such as atherosclerosis,
retinopathy and, probably, neuropathy. Although microalbuminuria is no
t specific for diabetic complications, it has been most extensively st
udied in diabetics. The rate of urinary albumin excretion can also be
used to determine therapeutic response to pharmacologic and lifestyle
interventions such as diet, smoking cessation and physical activity. T
he pathophysiology of microalbuminuria and its clinical significance i
n diabetes is presented, along with a discussion of measurement issues
and implications for clinical management. An algorithm for the evalua
tion of diabetic patients is included.